These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8477129)

  • 1. Therapeutic drug monitoring in ambulatory care.
    Goode MA; Gums JG
    Ann Pharmacother; 1993 Apr; 27(4):502-5. PubMed ID: 8477129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist compensation for ambulatory patient care services.
    Bradberry JC; Srnka Q
    Am J Manag Care; 1998 Dec; 4(12):1727-35; quiz 1736-7. PubMed ID: 10339105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of performance metrics to assess pharmacists' activities in ambulatory care clinics.
    Schmidt L; Klink C; Iglar A; Sharpe N
    Am J Health Syst Pharm; 2017 Jan; 74(1):e76-e82. PubMed ID: 28007725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic terminology in obtaining reimbursement for pharmacists' cognitive services.
    Nutescu EA; Klotz RS
    Am J Health Syst Pharm; 2007 Jan; 64(2):186-92. PubMed ID: 17215470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pharmacists' barriers to the implementation of medication therapy management services.
    Lounsbery JL; Green CG; Bennett MS; Pedersen CA
    J Am Pharm Assoc (2003); 2009; 49(1):51-8. PubMed ID: 19196597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current trends in outpatient pharmacy services and billing.
    Beatty SJ; McCormick KM; Beale DJ; Bruggeman AM; Rodis JL; Mehta BH; Bennett MS
    J Am Pharm Assoc (2003); 2012; 52(2):154-60. PubMed ID: 22370377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obtaining reimbursement for oncology pharmacy services provided to ambulatory patients.
    Chong SF; Rospond RM
    Am J Hosp Pharm; 1993 Oct; 50(10):2057-8. PubMed ID: 8238043
    [No Abstract]   [Full Text] [Related]  

  • 8. Billing for pharmacists' cognitive services in physicians' offices: multiple methods of reimbursement.
    Scott MA; Hitch WJ; Wilson CG; Lugo AM
    J Am Pharm Assoc (2003); 2012; 52(2):175-80. PubMed ID: 22370380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustainable business models: systematic approach toward successful ambulatory care pharmacy practice.
    Sachdev G
    Am J Health Syst Pharm; 2014 Aug; 71(16):1366-74. PubMed ID: 25074956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third party reimbursement for pharmacist services: why has it been so difficult to obtain and is it really the answer for pharmacy?
    Ganther JM
    J Am Pharm Assoc (Wash); 2002; 42(6):875-9. PubMed ID: 12482013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy benefits management and ambulatory pharmacy services.
    Strandberg LR
    Pharm Pract Manag Q; 1996 Jan; 15(4):19-26. PubMed ID: 10153841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pharmacist-provided medication therapy management services in an oncology ambulatory setting.
    Watkins JL; Landgraf A; Barnett CM; Michaud L
    J Am Pharm Assoc (2003); 2012; 52(2):170-4. PubMed ID: 22370379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a business-practice model for pharmacy services in ambulatory settings.
    ; Harris IM; Baker E; Berry TM; Halloran MA; Lindauer K; Ragucci KR; McGivney MS; Taylor AT; Haines ST
    Pharmacotherapy; 2008 Feb; 28(2):285. PubMed ID: 18225974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of pharmacist-reimbursed drug therapy modification.
    Look KA; Mott DA; Kreling DH; Peterson EJ; Staresinic AG
    J Am Pharm Assoc (2003); 2011; 51(1):58-64. PubMed ID: 21247827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reimbursement model for pharmacist-directed medication therapy management.
    Lloyd KB; Evans RL
    J Am Pharm Assoc (2003); 2012; 52(2):161-9. PubMed ID: 22370378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
    Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
    Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IMPROVE study: background and study design. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.
    Carter BL; Malone DC; Valuck RJ; Barnette DJ; Sintek CD; Billups SJ
    Am J Health Syst Pharm; 1998 Jan; 55(1):62-7. PubMed ID: 9437477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients.
    Cowper PA; Weinberger M; Hanlon JT; Landsman PB; Samsa GP; Uttech KM; Schmader KE; Lewis IK; Cohen HJ; Feussner JR
    Pharmacotherapy; 1998; 18(2):327-32. PubMed ID: 9545151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PharmacistCARE: description of a pharmacist care service and lessons learned along the way.
    Divine H; Nicholas A; Johnson CL; Perrier DG; Steinke DT; Blumenschein K
    J Am Pharm Assoc (2003); 2008; 48(6):793-802. PubMed ID: 19019810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.